Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major.

Hussein AA, Al-Zaben A, Ghatasheh L, Natsheh A, Hammada T, Abdel-Rahman F, Abu-Jazar H, Sharma S, Najjar R, Frangoul H
Pediatr Blood Cancer. 2013 60 (8): 1345-9

PMID: 23424175 · DOI:10.1002/pbc.24493

MeSH Terms (26)

Adolescent Adult Antilymphocyte Serum beta-Thalassemia Busulfan Child Child, Preschool Cyclophosphamide Disease-Free Survival Female Follow-Up Studies Graft Rejection Graft Survival Hematopoietic Stem Cell Transplantation Humans Immunologic Factors Infant Male Myeloablative Agonists Retrospective Studies Risk Factors Survival Rate Tissue Donors Transplantation, Homologous Transplantation Conditioning Vidarabine

Connections (1)

This publication is referenced by other Labnodes entities:

Links